Latest filing published 14 Aug 2019 for Keurig Dr Pepper Inc., €357k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 11 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +7.4%Entry US$27.84 · Close at T+365 US$29.89
- -29.6%Entry US$27.83 · Close at T+365 US$19.60
- -10.0%Entry US$27.23 · Close at T+365 US$24.51
- +10.2%Entry US$26.12 · Close at T+365 US$28.78
- +12.5%Entry US$25.95 · Close at T+365 US$29.19
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Brian Andrew Loucks: trading record in brief
Brian Andrew Loucks is a declared insider of Keurig Dr Pepper Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 9 July 2018 to 14 August 2019, the count stands at 12 filings.
No open-market sale appears; the market trades are 11 purchases worth €1.9M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant. Since January 2019: 4 purchases and no sales on the market.
In size, the median ticket on the buying side is €158k. 11 out of 11 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. Looking at 11 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +4.6%. This is a record of the past, not a forecast.
The newest entry dates from 14 August 2019: an open-market purchase of €357k, in Keurig Dr Pepper Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Brian Andrew Loucks
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 14,000 shares@ US$28.5018.4% of flowCommon StockSEC:0001209191-19-045946:0Canonical exit: 11 Nov 2019 (T+90)
- 4,554 shares@ US$27.765.8% of flowCommon StockSEC:0001209191-19-045946:1Canonical exit: 12 Nov 2019 (T+90)
- 6,250 shares@ US$27.347.8% of flowCommon StockSEC:0001209191-19-019711:0Canonical exit: 12 Jun 2019 (T+90)
- 8,500 shares@ US$26.2910.3% of flowCommon StockSEC:0001209191-19-018457:0Canonical exit: 6 Jun 2019 (T+90)
- 17,500 shares@ US$26.0020.5% of flowCommon StockSEC:0001209191-18-062006:0Canonical exit: 10 Mar 2019 (T+90)
- 1,200 shares@ US$25.771.4% of flowCommon StockSEC:0001209191-18-061524:0Canonical exit: 6 Mar 2019 (T+90)
- 400 shares@ US$26.100.5% of flowCommon StockSEC:0001209191-18-061524:1Canonical exit: 7 Mar 2019 (T+90)
- 6,900 shares@ US$25.928.1% of flowCommon StockSEC:0001209191-18-060902:0Canonical exit: 3 Mar 2019 (T+90)
- 2,500 shares@ US$26.173.0% of flowCommon StockSEC:0001209191-18-059743:0Canonical exit: 19 Feb 2019 (T+90)
- 13,050 shares@ US$22.8613.2% of flowCommon StockSEC:0001209191-18-051501:0Canonical exit: 5 Dec 2018 (T+90)
- 10,900 shares@ US$22.8011.0% of flowCommon StockSEC:0001209191-18-049579:0Canonical exit: 3 Dec 2018 (T+90)
- 50,513 shares0Common StockSEC:0001209191-18-042348:0
12 of 12 declarations
